← SynDRA
GSK2256294
SynDRA canonical compound SYN0038565 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EPHX2 |
|---|
| Mechanism of action | epoxide hydolase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EPHX2 INHIBITOR
- Epoxide hydratase inhibitor
- EPHX2 MODULATOR
Cross-references
Synonyms
- GSK-2256294
- GSK-2256294A
- Gsk-2256294
- GSK 2256294A
- L33EX3XR0T
- RefChem:144546
- GSK2256294A
- UNII-L33EX3XR0T
- LQHDJQIMETZMPH-ZBFHGGJFSA-N
- GTPL9718
- orb1308251
- SCHEMBL2677671
- SCHEMBL29557121
- SCHEMBL29667411
- C21H24F3N7O
- GLXC-20745
- SVB09023
- BDBM50264106
- MFCD27987923
- AKOS030526273
- CS-5395
- NCGC00386723-01
- NCGC00386723-02
- NCGC00386723-03
- DA-53733
- HY-19644
- MS-28093
- E99026
- T15430
- BRD-K62738477-001-01-7
- gsk-2256294
Look up GSK2256294 in the interactive SynDRA portal →